Concepedia

Mark T. Wotkowicz

MT

2

Publications

118

Citations

2

H-Index

2009

Active since

Affiliations

Minerva Biotechnologies (United States)(Current)

Mark T. Wotkowicz is an author at Minerva Biotechnologies (United States) specializing in medicine, cancer research, and tumor biology.

Top concepts

Publications per year

2009–2011

2

Publications

2

MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cells

Shawn P. Fessler, Mark T. Wotkowicz, S. Mahanta et al. · Breast Cancer Research and Treatment · 2009 · 94 citations

, , +8

A Gold Nanoparticle Platform for Protein–Protein Interactions and Drug Discovery

A. Thompson, Amy K. Calhoun, Benoit J. Smagghe et al. · ACS Applied Materials & Interfaces · 2011 · 24 citations

, , +14

Rows per page

1–2 of 2